Nivolumab-related Sclerosing Cholangitis in Gastric Cancer

Intern Med. 2019 May 1;58(9):1197. doi: 10.2169/internalmedicine.2135-18. Epub 2019 Jan 10.
No abstract available

Keywords: gastric cancer; nab-paclitaxel; nivolumab; ramucirumab; sclerosing cholangitis.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cholangitis, Sclerosing*
  • Humans
  • Nivolumab
  • Paclitaxel
  • Programmed Cell Death 1 Receptor
  • Stomach Neoplasms*

Substances

  • Programmed Cell Death 1 Receptor
  • Nivolumab
  • Paclitaxel